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ABSTRACT  
          Hydrazones possess an azomethine –NHN=CH  group and 
are considered as derivatives of aldehydes and ketones in which 
the oxygen atom has been replaced by the NNH2 functional 
group. These are widely studied molecules owing to their ease of 
preparation and diverse pharmacological potential. This has led 
researchers to synthesize different heterocyclic compounds 
bearing hydrazones. Medicinal chemists across the world have 
done immense work on hydrazones and developed agents with 
better activity and low toxicity profiles. Following different 
synthetic protocols and through proper SAR studies differently 
substituted hydrazones have been developed and found to be 
active against different pharmcological targets. They are known 
to possess different biological activities viz. antimicrobial, anti-
inflammatory, anticancer, antimalarial etc. These observations 
have been guiding for the development of new hydrazones that 
possess varied biological activities. The review aims at 
highlighting the diverse biological activities of hydrazones. 
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INTRODUCTION 
Hydrazones are a class of organic 
compounds which possess the structure 
R1R2C=NNH2. They are related to ketone and 
aldehyde in which oxygen has been replaced 
with NNH2 group. These azometine -
NHN=CH- proton constitute an important 
class of compounds for new drug development. 
Hydrazones are formed by the reaction of 
hydrazine or hydrazide with aldehydes and 
ketones. They act as reactants in various 
important reactions such as hydrazone 
iodination, Shapiro reaction and Bamford-
Stevans reaction to form vinyl compounds. 
They act as intermediate in Wolff-Kishner 
reaction. Hydrazones can also be synthesized 
by the Japp-Klingemann reaction (from β-
ketoacids or β-ketoester’s and aryldiazonium 
salts). The N,N’-dialkyl type of hydrazones can 
be hydrolysed, reduced and oxidized this leads 
to the formation of amines by reduction of N-
N bond. The C=N double bond in hydrazones 
are important compounds in drug design as 
they act as ligands for metal complexes, 
organocatalysis and synthesis of organic 
compounds. 
The C=N bond of hydrazone and 
terminal nitrogen atom containing a lone pair 
of electron is responsible for the physical and 
chemical properties. The C-atom in hydrazone 
has both electrophilic and nucleophilic 
character and both the N-atoms are 
nucleophilic although the amino type nitrogen 
is more reactive. Due to these properties 
hydrazones are widely used in organic 
synthesis. The chemical structure of hydrazone 




The overuse of chemicals against various 
infectious diseases has led to rapid emergence 
of resistivity against different bacteria. 
Therefore, the search for antimicrobials is a 
never ending task. Consequently, there has 
been an immense research on hydrazones as 
antibacterial agents. Sharma et al. (2011) 
reported the antibacterial activity of hydrazine 
derivatives (1) against various bacterial strains. 
Hydrazine derivatives (2, 3) synthesized by 
Jubie et al. (2010) are promising antibacterial 
agents. Ozkay et al. (2010) synthesized novel 
benzimidazole    derivatives  bearing   hydrazone  
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moiety (4) and evaluated their antibacterial 
activity against different bacterial strains. Novel 
chloropyrrole derivatives of aroylhydrazone (5) 
developed by Rane et al. (2010) have been 
evaluated for antibacterial activity against 
different bacterial strains. Edress et al. (2010) 
synthesized some hydrazonoyl substituted 
pyrimidinones (6, 7) and evaluated their 
antibacterial activity. Govindasami et al. (2011) 
synthesized vanillin based hydrazine derivatives 
(8, 9) and reported their antibacterial             
activity specifically against Staphylococcus aureus 
and Pseudomonas aeruginosa.  Ajani et al. (2010) 
have reported the antibacterial activity of              
2-quinoxalinone-3-hydazine derivative (12) 
against different bacterial strains. Lee et al. 
(2012) synthesized various hydrazones (13, 14) 
as selective inhibitors of Staphylococcus aureus β- 
ketoacyl carrier proteinsynthase III. The 
compound was found to have an MIC of 1-
2µg/mL. Aryloxyacetic acid hydrazide (15) 
having promising antibacterial activity with 
MIC of 4.1-16.5µg/mL against an array of         
bacterial strains has been reported by Wahab et 
al. (2012). Rasras et al. (2010) synthesized 
various cholic acid based hydrazones (22) and 
screened them as antibacterials. The best 
compound among the series is reported to have 
MIC of 2µg/mL and 3.9µg/mL against 
Escherichia faecalis and Escherichia coli. Anthra-
quinone based hydrazones (23) synthesized by 
Gouda et al. (2010) are reported to have promi-
sing bacteriostatic activity against P. auriginosa. 
Kumar et al. (2010) synthesized various 
benzyledine-hydrazides (24) and reported their   
bactericidal    activity   against   S.  aureus. The 
agent is reported to have a MIC of 1.5µM/mL. 
Abdel-Wahab et al. (2011) synthesized different 
hydrazone bearing imidazoles (25). The 
synthesized compounds were screened for their 
antibacterial activity against numerous bacterial 
strains. Vijesh et al. (2010) synthesized 2,4- di-
substituted thiazoles (26). The compound has a 
MIC value ranging between 1.6µg/mL and 
3.1µg/mL when tested against different strains. 
Tuberculosis is a chronic infection 
caused by different strains of Mycobacterium 
tuberculosis. The bacterium affects almost any 
organ but the favorite site is lung. The activity 
of the newer agents is mostly tested against  
virulent H37Rv strain. Few hydrazone 
derivatives (27) synthesized by Raja et al. (2010) 
have been screened and reported to have MIC 
of 6.3µg/mL. 4-hydroxy-8-trifluromethyl-
quinoline derivatives (31) with a MIC of 
0.625µg/mL have been reported by Thomas et 
al. (2011). Vavrikova et al. (2011) synthesized 
fluorine-containing hydrazones (32) with a MIC 
of 0.5µg/mL and a selectivity index of 1268.6 
Pavan et al. (2010) synthesized some hydrazines 
(35) with promising results. Ferrocenyl 
hydrazones (38, 39) with a MIC of 0.75 and 
0.7µmol/L have been reported by Maguene et 
al. (2011) Mahajan et al. (2011) synthesized 
ferrocene-based hydrazone derivatives (43) 
with significant potential. Eswaran et al. (2010) 
synthesized hydrazones (44) with a MIC of 
6.25µg/mL. Jordao et al. (2011) synthesized 
hydrazone derivatives (45) with antitubercular 
activity. The compound is reported to have 
MIC of 2.5µg/mL. Fungal species are known 
to cause many superficial and systemic 
infections in humans, plants as-well-as 
livestock. Hydrazone derivatives (49) 
synthesized by Ozdemir et al. (2010) after being 
screened against different Candida spp have been 
reported to have promising antifungal potential. 
Viruses are obligate parasites which 
require cellular machinery of the host to 
prosper. They are capable of causing immense 
harm to host. Hydrazone derivatives (53, 54) 
synthesized by Jin et al. (2010) have been 
reported to have EC50 value of 0.6 and 0.4µM 
respectively against HIV1-CA. 
 
Analgesic and Anti-inflammatory activity 
Much work has been done describing the 
analgesic and anti-inflammatory potential of 
hydrazides. Harnandez et al. (2012) reported 
analgesic and anti-inflammatory activity of 
furoxanyl-N-acylhydrazones (55, 56). Rajitha et 
al. (2011) evaluated the anti-inflammatory 
activity of some aryl hydrazones (58) and got 
good results. Moldovan et al. (2011) synthesized 
various hydrazone derivatives (60) and reported 
them to have promising in-vivo anti-inflamma-
tory activity. El-Sayed et al. (2011) synthesized 
hydrazone derivatives (62) with selective          
COX-2 inhibition. The compound is reported 
to    have    an    ED50   value   of 0.2 mmol/Kg.  
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Benzo-thiophene derivatives (66) with 
inhibition of 50.2% have been developed by 
Isloor et al. (2010).  
 
Anticancer activity 
Cancer is a lethal group of diseases with 
a high level of penetrating potency affecting 
almost every organ of the body. Al-Said et al. 
(2011) synthesized compounds (67) active 
against human breast cancer cell lines MCF7. 
Hassan et al. (2011) synthesized pyrazole based 
hydrazone derivatives (69) with potential to 
treat breast carcinoma. Kendall et al. (2012) 
evaluated some derivatives (70) as PI3K p110α 
inhibitors. P13K are signaling proteins in 
different cell types responsible for 
phosphorylation of lipids in cell membranes.  
Kumar et al. (2012) synthesized various 
bis(indolyl) based hydrazones (72, 73) active 
against multiple cancer cell lines. Effenberger et 
al. (2010) reported a hydrazone derivative (75) 
with potent activity against HL-60 leukaemia 
and 518A2 melanoma. Acylhydrazones (79) by 
Cui et al. (2010) have been reported to have 
potent activity against the human 
promyelocytic leukemic cells (Hl-60). Copper 
based hydrazone derivatives (82) are reported 
to act against integrin β4 in H322 lung 
carcinoma cell lines by Fan et al. (2010). 
Palladium based hydrazones (86) by Abu-
Surrah et al. (2010) have been reported to be 
active against human head and neck squamous 
carcinoma cell lines SQ20B and SCC-25. 2-
phenylindole based hydrazone (87) synthesized 
by El-Nakkady et al. (2012)  have been 
developed against breast carcinoma cell lines 
and reported to have an IC50 of 1.60nM. 
 
Central Nervous System Activity  
Hydrazones are reported to have activity 
against various illnesses’ of central nervous 
system.     Hydrazones    (88)    synthesized   by  
                      
 
                
 
             
 
            
 
                      
 
Figure 1. Chemical structure of hydrazone derivatives no.1-42  
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Gage et al. (2011) have been evaluated for 
inhibition of PDE10A- a phosphodiesterase 
responsible for neurological and psychological 
disorder such as Parkinson’s, Schizophrenia 
and Huntington’s disease. Kaushik et al. (2010) 
reported the anticonvulsant potential of some 
hydrazone derivatives (91, 92) having long 
duration of action and a rapid onset of action.  
Antidepressant activity of hydrazones 
(93) has been reported by de Oliveira et al. 
(2011). Catto et al. (2010) reported the in-vitro         
β-amyloid aggregation inhibition of hydrazone 
derivatives (96) with an IC50 of 23µM.  
 
Antiprotozoal activity 
Protozoal diseases are highly prevalent in 
tropical countries affecting human and animal 
populations’ and causing suffering and death. 
Caputto et al. (2011) reported the inhibitory 
activity of hydrazones (98, 99) against cruzipen- 
a major cysteine protease of T.cruzi. Hayat et al. 
(2010) reported the in-vitro antiamoebic activity 
of hydrazones (102, 103) against the HM1:IMSS 
strain of Entamoeba histolytica. The compounds 
are reported to have IC50 value of 0.03 and 
0.04µM respectively. Vaio et al. (2009) 
synthesized hydrazone derivatives (106, 107)  




           
 
            
 
 
   
Figure 2. Chemical structure of hydrazone derivatives no.44-75  
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them to be of high utility in Chagas disease. 
Siddiqui et al. (2012) described the antiamoebic 
activity of hydrazone derivatives (108, 109). 
Romeiro et al. (2009) developed hydrazone 
derivatives (110, 111) as cruzin inhibitors.  
Aponte et al. (2010) evaluated the anti-
trypanosomal activity of hydrazone derivatives 
(112).                        
Miscellaneous activity 
In addition to the mentioned activities 
hydrazines are also reported to have other 
activities, as mentioned below: 
 
Antioxidant activity 
Oxidation reactions are crucial for        
sustenance  of  life  but  they   can also be damaging.  
 
 
        
 
    
 
          
 
      
 
  
Figure 3. Chemical structure of hydrazone derivatives no.81-111  
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Oxidative stress is the cause of different 
pathological states. Hydrazone derivatives (116, 
117) synthesized by Musad et al. (2011) are 
reported to have  radical scavenging activity 
(RSA) at the concentration of 10µg/mL. 
Abdel-Wahab et al. (2011) evaluated imidazoline 
based hydrazones (118, 119) by 2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid (ABTS) 
assay method and reported them to have 
promising antioxidant activity. 
 
Cardioprotective activity 
Despite the intensive drug research 
cardiovascular diseases still remain the leading 
cause of mortalities worldwide. El-Sabbagh et 
al. (2010) synthesized octahydroquinazoline-
hydrazones (121, 122, 123) and reported them 
to be potential hypotensive agents. The activity 
was attributed to α-blockage. The chemical 
structure of hydrazone derivatives no.112-132 
were showed in figure 4. 
 
Antiplatelet activity 
Antiplatelets decrease platelet aggre-
gation, hold back the formation of thrombus. 
Jordao et al. (2009) synthesized hydrazone 
derivatives (126, 127, 128) and evaluated them 
for in-vitro antiplatelet activity. 
 
Antiparasitic activity 
Ali et al. (2010) evaluated the in-vitro anti 
parasitic activity of hydrazone derivatives (129, 
130) against Ctenocephalides felis and Rhipicephalus 
sanguineusas. LD50 of 0.39 and 0.28µg/tick has 
been reported. 
Aslam et al. (2011) synthesized 
hydrazone derivatives (132) as urease inhibitors. 
Urease catalyzes the hydrolysis of urea to 
ammonia and carbamate. This is beneficial for 
the pathogenesis of urolithiasis, pyelonephrities, 
ammonia and hepatic encephalopathy, hepatic 
coma and urinary catheter encrustation.  
 
   
 
      
 
 
   
 
      
 
Figure 4. Chemical structure of hydrazone derivatives no.112-132  
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CONCLUSION 
The review highlights the use of 
hydrazones as lead for development of newer 
agents. As mentioned the moiety possesses an 
array of activity. With proper synthesis and 
structure activity relationship, potential 
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